The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 16, 2025
Filed:
Oct. 13, 2021
Applicant:
Attica Sciences Ltd., Manchester, GB;
Inventor:
Dimitrios Iliopoulos, Los Angeles, CA (US);
Assignee:
ATTICA SCIENCES LTD., Manchester, GB;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/7048 (2006.01); A61K 31/22 (2006.01); A61K 31/222 (2006.01); A61K 31/265 (2006.01); A61K 31/404 (2006.01); A61K 35/17 (2025.01); A61P 35/00 (2006.01); A61P 37/06 (2006.01); C07C 69/738 (2006.01); C07C 327/22 (2006.01); C07D 209/12 (2006.01); C07H 17/04 (2006.01);
U.S. Cl.
CPC ...
A61K 31/7048 (2013.01); A61K 31/22 (2013.01); A61K 31/222 (2013.01); A61K 31/265 (2013.01); A61K 31/404 (2013.01); A61K 35/17 (2013.01); A61P 35/00 (2018.01); A61P 37/06 (2018.01); C07C 69/738 (2013.01); C07C 327/22 (2013.01); C07D 209/12 (2013.01); C07H 17/04 (2013.01);
Abstract
Analogues of oleuropein and oleacein and pharmaceutically acceptable salts thereof and processes for the preparation of these compounds are disclosed. The invention further relates to use of oleuropein and oleacein analogues for the treatment of inflammatory disorders, cardiometabolic disorders, and cancer.